Trial Profile
Proposed Study of CLL Samples
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Cyclophosphamide (Primary) ; Fludarabine (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Biomarker; Pharmacodynamics
- 16 May 2017 Status changed from not yet recruiting to completed.